NONOF:OTCMKTS
Novo Nordisk A/S
38,38 US$
arrow_upward
+0,08%(+0,031) 1K
30-sen, 9:34:24 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNONOF tikeri uchun statistika yaratilmoqda...
Ochish
38,01 US$
Yuqori
38,38 US$
Past
38,01 US$
Bozor kapitali
127,96 mlrd
Oʻrtacha hajm
135,37 ming
Hajmi
13,00
52 haftalik eng yuqori
64,75 US$
52 haftalik eng past
34,00 US$
Beta
0,63
Muomaladagi aksiyalar
3,39 mlrd
Xodimlar soni
67 ming
Ochish
38,01 US$
Yuqori
38,38 US$
Past
38,01 US$
Bozor kapitali
127,96 mlrd
Oʻrtacha hajm
135,37 ming
Hajmi
13,00
52 haftalik eng yuqori
64,75 US$
52 haftalik eng past
34,00 US$
Beta
0,63
Muomaladagi aksiyalar
3,39 mlrd
Xodimlar soni
67 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Stock Titan
·
1 soat oldin
An experimental obesity drug changed brain responses to tempting foods and reduced cravings
Investing.com
·
3 soat oldin
Patients switching to Novo Nordisk’s Wegovy pill from shots lose more weight in real-world study By Reuters
The Motley Fool
·
9 soat oldin
Novo Nordisk Gives Uninspiring Outlook
Profil
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Novo Nordisk A/S haqida
CEOMaziar Mike Doustdar
Xodimlar soni66,7 ming
Asos solingan21-dek, 1923
Bosh ofislarBagsværd, Capital Region of Denmark, Daniya
Sektor-
Veb-saytnovonordisk.com